Stay Updated: Posts | Comments

  • 8th August 2010 - By Joel Lord

    HCGIn the race to the top of the Vaccine manufacturing foodchain product side effects such as infertility are being overlooked in favor of scientific advancement. One competitor, U.S. firm Celldex Theraputics are vying for major positioning in the ranks with a radical new generation cancer vaccine now in development for the treatment of advanced colorectal, pancreatic, bladder, ovarian, cervical and breast cancers. Purported to eradicate cancer cells, it is “designed to deliver the antigen hCG-β to dendritic cells (DCs) and induce hCG-β specific cellular and humoral immune responses, thus activating the immune system against cancers that express hCG-β”.

    This process of introducing hCG into the bloodstream effectively neutralizes a woman’s reproductive capacity. We now know the Tetanus shots given in the 1990’s were contaminated with Immune-Suppressant Contraceptive in the form of hCG, a hormone crucial to female fertility balance. By inserting hCG next to a deadly live virus into the body the immune system reacts to both intruders as hostile – end result saw hundreds of thousands of healthy women inadvertently sterilized by the shots.

    hcg-pregnyl-organon_maxHCG hormone & population control: ‘In 1989 research was conducted by the National Institute of Immunology in New Delhi India on the use of ‘carriers’ such as Tetanus Toxoid and Diphtheria to bypass the immune system and deliver the female hormone called human chorionic gonadotrophin (hCG). The research paper was carried in the Oxford University Press in 1990 and was titled “Bypass by an alternate ‘carrier’ of acquired unresponsiveness to hCG upon repeated immunization with tetanus-conjugated vaccine.

    While hCG is required to maintain pregnancy, the injection of hCG bound to Tetanus Toxoid triggers an auto-immune response, thus causing sterilization. The NII research cited above used four women as test subjects – who had been surgically sterilized prior to the experiment – and found that multiple doses of the Tetanus Toxoid hCG carrier vaccine was required in order to achieve the desired results. Research also found that if an alternate carrier such as Diphtheria was used as a booster in combination with Tetanus the sterilization vaccine would be more effective.’
    http://www.oldthinkernews.com/?p=201

    Tetanus‘During the early 1990s, the World Health Organization had been overseeing massive vaccination campaigns against tetanus in a number of countries, among them Nicaragua, Mexico, and the Philippines. In October 1994, HLI received a communication from its Mexican affiliate, the Comite’ Pro Vida de Mexico, regarding that country’s anti-tetanus campaign. Suspicious of the campaign protocols, the Comite’ obtained several vials of the vaccine and had them analyzed by chemists.

    Some of the vials were found to contain human chorionic gonadotrophin (hCG), a naturally occurring hormone essential for maintaining a pregnancy. Only women were vaccinated, and only the women between the ages of 15 and 45. (In Nicaragua the age range was 12-49).’
    http://www.thinktwice.com/birthcon.htm

    A priest, president of Human Life International (HLI) based in Maryland, has asked Congress to investigate reports of women in some developing countries unknowingly receiving a tetanus vaccine laced with the anti-fertility drug human chorionic gonadotropin (hCG). If it is true, he wants Congress to publicly condemn the mass vaccinations and to cut off funding to UN agencies and other involved organizations. The natural hormone hCG is needed to maintain pregnancy. The hormone would produce antibodies against hCG to prevent pregnancy. In the fall of 1994, the Pro Life Committee of Mexico was suspicious of the protocols for the tetanus toxoid campaign because they excluded all males and children and called for multiple injections of the vaccine in only women of reproductive age. Yet, one injection provides protection for at least 10 years.

    The Committee had vials of the tetanus vaccine analyzed for hCG. It informed HLI about the tetanus toxoid vaccine. HLI then told its World Council members and HLI affiliates in more than 60 countries. Similar tetanus vaccines laced with hCG have been uncovered in the Philippines and in Nicaragua. In addition to the World Health Organization (WHO), other organizations involved in the development of an anti-fertility vaccine using hCG include the UN Population Fund, the UN Development Programme, the World Bank, the Population Council, the Rockefeller Foundation, the US National Institute of Child Health and Human Development, the All India Institute of Medical Sciences, and Uppsala, Helsinki, and Ohio State universities. The priest objects that, if indeed the purpose of the mass vaccinations is to prevent pregnancies, women are uninformed, unsuspecting, and unconsenting victims.’
    http://www.ncbi.nlm.nih.gov/pubmed/12346214

    ‘Human Chorionic Gonadotropin (hCG) is a hormone produced in pregnancy that is made by the developing embryo after conception and later by the placenta. Its role is to prevent disintegration of the hormonal structure of the ovaries and thereby maintains progesterone production that is critical for pregnancy in women. hCG also affects the immune tolerance of the pregnancy.

    Ironically, the hCG hormone the researchers are trying to destroy is actually used during female infertility treatments in order to stimulate the release of eggs from the ovaries. Temporary depression and disruption of hCG causes a range of hormonal imbalances and is considered a leading cause of miscarriages. Consequently, many once infertile women may suddenly conceive with repeated injections of hCG.

    One of the primary reasons that women who abuse cocaine can no longer conceive is because of hCG disruption. Cocaine inhibits hCG concentrations in maternal circulation which affects secretion by the placenta required to maintain pregnancy.

    The biological processes of how hCG disrupts pregnancy also differ between different species so translating biological mechanisms from animal testing to humans is redundant. Regardless, drug studies continue to use these results if the conclusions/outcome are favourable to their objectives.’
    http://www.vaccinationcouncil.org/vaccination/articles/toxic-cancer-vaccine-being-developed-will-destroy-human-fertility.html

    The latest hCG Recombinant vaccine has just been proposed for “family planning” (aka Eugenics) in India. History is about to repeat itself: ‘Possibility and potential of a vaccine against human chorionic gonadotropin for family planning: The population of the world is continuing to grow and is projected to reach 7 billion by 2012, according to the 2008 revision of the official United Nations population estimates and projections (UN Population Division/DESA). India has a population of 1.16 billion and it is growing at the rate of 1.548% (15.5 millions per year according to 2009 estimate) every year, which is roughly equal to the entire population of Australia. This many extra numbers pose demands for food, water, education and jobs. India has 2.4% of geographical area of the world, whereas its population is 15% of the world’s population. We are already about six times over populated. Leave aside land, water essential for life and agriculture is becoming scarce day by day. Although efforts are being made to harness water resources and enhance productivity of the land, there is need to limit the size of the family voluntarily by providing safe and acceptable methods for family planning.’ Trials: ‘The efficacy of the vaccine to prevent pregnancy was high with only one pregnancy recorded in 1224 cycles above 50 ng/ml…efficacy above 90% is required and desirable.’
    http://www.ias.ac.in/currsci/25jul2010/169.pdf

    CelldexTherapeutics-CLDX-042710CELLDEX: ‘Our lead APC Targeting Technology™ product candidate, CDX-1307, is in development for the treatment of cancers that express the beta chain of human chorionic gonadotropin ( hCG-β). hCG-β is an established tumor-associated antigen that is over-expressed in a variety of common cancers including those of the colon, lung, pancreas, esophagus, breast, bladder, cervix, stomach, and prostate, but not expressed in most normal tissues. Elevated hCG-β serum levels and/or tissue expression have been shown to be an independent predictor of poor disease outcome and associated with a more aggressive disease course. Mechanistically, it has been proposed that hCG-β may function at several different levels to facilitate cancer progression: as a transforming growth factor, an immunosuppressive agent, an inducer of metastasis, and/or as an angiogenic factor. CDX-1307 is composed of a human monoclonal antibody targeting the mannose receptor found on dendritic cells, fused to the hCG-β antigen. This antibody-vaccine is designed to deliver hCG-β to dendritic cells and induce cellular & humoral immune responses against hCG-β, thus activating the patient’s immune system against cancers that express hCG-β. CDX-1307 has been evaluated for the treatment of advanced colorectal, pancreatic, bladder, ovarian and breast cancers in 2 Phase 1 trials. Phase 2 trial of CDX-1307 in treatment of newly diagnosed bladder cancer underway.’
    http://www.celldextherapeutics.com/wt/page/trials_cdx1307_breast

    ORIGINS OF CDX-1307: ‘A team of researchers from Middlesex University have developed a vaccine approach which could be the first of a whole new generation of cancer drugs with the potential to target specific cancers at source. This technique could lead to far quicker treatment of aggressive cancers, with patients experiencing fewer of the side-effects which chemotherapy often causes.

    Middlesex UWorld expert in biomedical science, Professor Ray Iles, and colleagues at Middlesex University’s Centre for Investigative and Diagnostic Oncology, are currently working with US pharmaceutical company, Celldex Therapeutics, to test the vaccine in clinical trials involving patients who have recently been diagnosed with bladder cancer. Initial results suggest that the lives and prognoses for thousands of cancer sufferers may improve radically and it is thought that the technique could ultimately delay the onset of certain types of cancer.

    Bladder cancer affects four times as many men as women, with 10,000 new cases being diagnosed in the UK each year. It is the fourth most common cancer in men and is the sixth most common cause of cancer death amongst men in the UK. At present, 75% of cases are lethal. The vaccine will be trialled over a five year period, amongst a group of 60 newly-diagnosed patients with the cancer.

    For Professor Iles, this is a real highpoint in a twenty-year research career in biomedical science. In 1987 he discovered that certain cancers, including bladder cancer, produce a fragment of the pregnancy hormone hCGβ – known in the science world as ‘HCG’ – which encourages aggressive activity by cancerous cells. Since then, a series of studies have been conducted by Professor Iles and Dr Stephen Butler, another member of the Middlesex team, culminating in the development of the vaccine by Celldex. The vaccine targets and neutralises the cells producing this hormone, before these cells have the chance to attack other, healthy cells.

    Professor Iles said: “The vaccine has the potential to help us make rapid advances in the treatment of this invasive cancer. It appears to block cancer-activating hormones, which in turn reduces the growth of tumours in distant organs – secondary cancers known as metastases. The same molecule occurs in both cervical and pancreatic cancers, and so in time, this type of vaccine could offer treatment benefits across a range of other highly invasive cancers too”.’
    http://www.mdx.ac.uk/aboutus/news-events/news/bladdercancerresearch.aspx

    CLINICAL TRIALS UNDERWAY: A Study of the CDX-1307 Vaccine Regimen in Patients With Newly Diagnosed Muscle-Invasive Bladder Cancer (The “N-ABLE” Study)
    http://www.clinicaltrials.gov/ct2/show/NCT01094496?term=CDX-1307&rank=3

    UPDATE: The Rockefeller Foundation funded HCG Hormone Vaccine research
    “…several types of drugs are known to diminish male fertility, but those that have been tested have serious problems of toxicity. Very little work is in progress on immunological methods, such as vaccines, to reduce fertility, and much more research is required if a solution is to be found here.”
    http://www.rockefellerfoundation.org/uploads/files/1496d619-017d-4b13-8a64-fce8ed4f785d-1968.pdf
    http://www.infowars.com/rockefeller-foundation-developed-vaccines-for-%E2%80%9Cmass-scale%E2%80%9D-fertility-reduction/

    “The work on LHRH and HCG vaccines was supported by research grants of The Rockefeller Foundation.”
    http://humupd.oxfordjournals.org/cgi/reprint/3/4/301.pdf

    Related Articles:

    VRM Worldwide Autism Study
    http://vaccineresistancemovement.org/?page_id=5463

    VRM: The Problem With Vaccines Part 1
    http://vaccineresistancemovement.org/?p=488

    VRM: The Problem With Vaccines Part 2 – Synergistic Effect of Heavy Metal Toxicity On The Body
    http://vaccineresistancemovement.org/?p=6097

    VRM: Vaccine Clinic – A Concise Compendium To The Problem With Vaccines
    http://vaccineresistancemovement.org/?p=6278

    VRM: The Problem With Vaccines Part 3 – Synthetic Genomics & The Death Of Natural Immunity
    http://vaccineresistancemovement.org/?p=6880

    VRM: A Concise Compendium To The Problem With Vaccines Part 3 – Synthetic Genomics & The Death Of Natural Immunity
    http://vaccineresistancemovement.org/?p=7283

    VRM: The Problem With Vaccines Part 4 – Primary Aspects of Vaccine Toxicity Affecting Body
    http://vaccineresistancemovement.org/?p=8787

    VRM: The Problem With Vaccines Part 5A – Detoxification & Restoration of the Body
    http://vaccineresistancemovement.org/?p=8836

    VRM: The Problem With Vaccines Part 5B – Detoxification & Restoration of the Body
    http://vaccineresistancemovement.org/?p=8847

    VRM: Vaccine Ingredients
    http://vaccineresistancemovement.org/?p=979

    VRM: Family Charts Gradual Decline Of Daughter
    http://vaccineresistancemovement.org/?p=3156

    VRM: Autism – Steps To Take Toward Prevention
    http://vaccineresistancemovement.org/?p=3028

    VRM: Health Matters Part 1
    http://vaccineresistancemovement.org/?p=6719

    VRM: Health Matters Part 2
    http://vaccineresistancemovement.org/?p=6746%EF%BB%BF

    VRM: Alternative Cancer Cures That Work
    http://vaccineresistancemovement.org/?p=3729

    VRM: Pregnancy Tips
    http://vaccineresistancemovement.org/?p=3270

    VRM: The Vanishing Sperm Count
    http://vaccineresistancemovement.org/?p=4639

    VRM: Media Spin & Swine Flu Hysteria
    http://vaccineresistancemovement.org/?p=2347

    VRM: H1N1 Vaccine Surplus From 2009 Reveals Growing Distrust of Gov’t & WHO – Cost To Taxpayers Exceeds 2.5 Billion
    http://vaccineresistancemovement.org/?p=4969

    VRM: Flu Death Statistics – WHO & The Big Lie
    http://vaccineresistancemovement.org/?p=784

    VRM: Canada’s 2010-11 Flu Vaccine A Deadly Concoction
    http://vaccineresistancemovement.org/?p=5692

    VRM: United States 2010-11 Flu Vaccine Afluria – Buyer Beware
    http://vaccineresistancemovement.org/?p=5271

    VRM: Australian Vaccine Scandal
    http://vaccineresistancemovement.org/?p=3377

    VRM: Polio – United Nations & The Great Cull
    http://vaccineresistancemovement.org/?p=4916

    VRM : Vaccine Industry Deception, Propaganda & Media Collusion
    http://vaccineresistancemovement.org/?p=197

    VRM: Birth of Medical & Scientific Dictatorship – Future Scenarios
    http://vaccineresistancemovement.org/?p=997

    VRM: H1N1 Bio-weaponry Incorporated
    http://vaccineresistancemovement.org/?p=884

    VRM : Aids & The WHO Connection – Criminal Intent
    http://vaccineresistancemovement.org/?p=1749

    VRM: Morgellons Syndrome & Chemtrails
    http://vaccineresistancemovement.org/?p=839

    VRM : Council On Foreign Relations 10/16/09- Major Influence on Government Vaccine Policy
    http://vaccineresistancemovement.org/?p=1880

    VRM: Closed Door CDC Meeting Reveals Industry Cover-up Of Heavy Metal Toxicity In Vaccines
    http://vaccineresistancemovement.org/?p=5935

    VRM: The Rockefeller Foundation Drafts A Post-Pandemic Scenario
    http://vaccineresistancemovement.org/?p=5102

    VRM : World Health Organization & Vaccine Manufacturers Implicated In Massive H1N1 Financial Scam Involving Kickbacks & Cover-ups
    http://vaccineresistancemovement.org/?p=4610

    VRM : Former Pharmaceutical Representative Gwen Olsen Exposes Systemic Industry Fraud
    http://vaccineresistancemovement.org/?p=5920

    VRM: Britain’s National Health Service – Criminal Syndicate Swindling Billions While Rapidly Destroying Health Care System
    http://vaccineresistancemovement.org/?p=4986

    VRM: UK Institutes Brand of Medical Martial Law With ‘Super-Vaccination’ Day
    http://vaccineresistancemovement.org/?p=4986

    VRM : The Awakening Has Begun
    http://vaccineresistancemovement.org/?p=6469

    VRM: Medical Martial Law In The US – Sleeping Giant Of Tyranny
    http://vaccineresistancemovement.org/?p=5865

    VRM : Multi-Virus Vaccine Quinvaxem Proving Deadly
    http://vaccineresistancemovement.org/?p=5219

    VRM: New Generation Cancer Vaccine Will Cause Infertility
    http://vaccineresistancemovement.org/?p=5311

    VRM: CDC-Gate Exposes A Trail of Fraud Behind Autism Studies
    http://vaccineresistancemovement.org/?p=5743

    VRM : Squaline – The Military Agenda Comes Home
    http://vaccineresistancemovement.org/?p=1797

    VRM Live – 01/28/11: Vaccine Resistance Movement founder Joel Lord discusses Synthetic Genomics, cloned cell vaccine technology & the death of natural immunity, gutter journalism & Dr. Wakefield’s imminent vindication with ‘Truth to Power’ host Paul Mabelis.
    http://www.blogtalkradio.com/empradio/2011/01/28/truth-to-power-thursday

    VRM Live – 11/04/10: Vaccine Resistance Movement founder Joel Lord lays out the whole vaccine process with Paul Mabelis; including heavy metal toxicity, synergy, pregnancy issues & the basic principles of natural health at risk.
    http://www.blogtalkradio.com/show.aspx?userurl=empradio&year=2010&month=11&day=05&url=truth-to-power-thursday

    VRM Live – 09/24/10: Vaccine Resistance Movement Founder Joel Lord & activist/radio host Jesse Calhoun lay it all out tonite. Topics include the VRM Worldwide Autism Study, Scientific/Medical dictatorship, Natural Rights & Vaccine Industry fraud exposed. Special thanks to host Paul Mabelis.
    http://www.blogtalkradio.com/empradio/2010/09/24/truth-to-power-thursday

    If you appreciate the efforts to bring this information forward do consider making a donation. Any amount, no matter how small will help enable me to carry on this invaluable research. See Paypal link on the VRM website (click on ‘Donate’ tab in upper right corner). Thank you all.

    logo.VRM_Ver.2.1

  • 4 Responses to “VRM: New Generation Cancer Vaccine Will Cause Infertility”

    Leave a Reply

    You must be logged in to post a comment.


<ul><li><strong>woo_ad_footer</strong> - false</li><li><strong>woo_ad_footer_adsense</strong> - </li><li><strong>woo_ad_footer_image</strong> - http://vaccineresistancemovement.org/wp-content/woo_uploads/4-3-banner-oxysilver.jpg</li><li><strong>woo_ad_footer_url</strong> - </li><li><strong>woo_alt_stylesheet</strong> - default.css</li><li><strong>woo_auto_img</strong> - false</li><li><strong>woo_cat_color_1</strong> - </li><li><strong>woo_cat_color_10</strong> - </li><li><strong>woo_cat_color_100</strong> - </li><li><strong>woo_cat_color_101</strong> - </li><li><strong>woo_cat_color_102</strong> - </li><li><strong>woo_cat_color_103</strong> - </li><li><strong>woo_cat_color_104</strong> - </li><li><strong>woo_cat_color_105</strong> - </li><li><strong>woo_cat_color_106</strong> - </li><li><strong>woo_cat_color_107</strong> - </li><li><strong>woo_cat_color_109</strong> - </li><li><strong>woo_cat_color_11</strong> - </li><li><strong>woo_cat_color_12</strong> - </li><li><strong>woo_cat_color_126</strong> - </li><li><strong>woo_cat_color_127</strong> - </li><li><strong>woo_cat_color_13</strong> - </li><li><strong>woo_cat_color_131</strong> - </li><li><strong>woo_cat_color_135</strong> - </li><li><strong>woo_cat_color_136</strong> - </li><li><strong>woo_cat_color_137</strong> - </li><li><strong>woo_cat_color_138</strong> - </li><li><strong>woo_cat_color_14</strong> - </li><li><strong>woo_cat_color_141</strong> - </li><li><strong>woo_cat_color_142</strong> - </li><li><strong>woo_cat_color_144</strong> - </li><li><strong>woo_cat_color_15</strong> - </li><li><strong>woo_cat_color_16</strong> - </li><li><strong>woo_cat_color_160</strong> - </li><li><strong>woo_cat_color_162</strong> - </li><li><strong>woo_cat_color_165</strong> - </li><li><strong>woo_cat_color_169</strong> - </li><li><strong>woo_cat_color_17</strong> - </li><li><strong>woo_cat_color_171</strong> - </li><li><strong>woo_cat_color_172</strong> - </li><li><strong>woo_cat_color_173</strong> - </li><li><strong>woo_cat_color_174</strong> - </li><li><strong>woo_cat_color_175</strong> - </li><li><strong>woo_cat_color_176</strong> - </li><li><strong>woo_cat_color_177</strong> - </li><li><strong>woo_cat_color_178</strong> - </li><li><strong>woo_cat_color_18</strong> - </li><li><strong>woo_cat_color_19</strong> - </li><li><strong>woo_cat_color_20</strong> - </li><li><strong>woo_cat_color_21</strong> - </li><li><strong>woo_cat_color_22</strong> - </li><li><strong>woo_cat_color_23</strong> - </li><li><strong>woo_cat_color_24</strong> - </li><li><strong>woo_cat_color_25</strong> - </li><li><strong>woo_cat_color_26</strong> - </li><li><strong>woo_cat_color_27</strong> - </li><li><strong>woo_cat_color_28</strong> - 03246B</li><li><strong>woo_cat_color_29</strong> - </li><li><strong>woo_cat_color_3</strong> - </li><li><strong>woo_cat_color_30</strong> - </li><li><strong>woo_cat_color_31</strong> - </li><li><strong>woo_cat_color_32</strong> - </li><li><strong>woo_cat_color_35</strong> - </li><li><strong>woo_cat_color_37</strong> - </li><li><strong>woo_cat_color_38</strong> - </li><li><strong>woo_cat_color_39</strong> - </li><li><strong>woo_cat_color_4</strong> - </li><li><strong>woo_cat_color_40</strong> - </li><li><strong>woo_cat_color_41</strong> - </li><li><strong>woo_cat_color_42</strong> - </li><li><strong>woo_cat_color_46</strong> - </li><li><strong>woo_cat_color_49</strong> - </li><li><strong>woo_cat_color_5</strong> - </li><li><strong>woo_cat_color_50</strong> - </li><li><strong>woo_cat_color_51</strong> - </li><li><strong>woo_cat_color_52</strong> - </li><li><strong>woo_cat_color_53</strong> - </li><li><strong>woo_cat_color_54</strong> - </li><li><strong>woo_cat_color_55</strong> - </li><li><strong>woo_cat_color_56</strong> - </li><li><strong>woo_cat_color_57</strong> - </li><li><strong>woo_cat_color_58</strong> - </li><li><strong>woo_cat_color_59</strong> - </li><li><strong>woo_cat_color_6</strong> - </li><li><strong>woo_cat_color_60</strong> - </li><li><strong>woo_cat_color_61</strong> - </li><li><strong>woo_cat_color_62</strong> - </li><li><strong>woo_cat_color_63</strong> - </li><li><strong>woo_cat_color_64</strong> - </li><li><strong>woo_cat_color_65</strong> - </li><li><strong>woo_cat_color_66</strong> - </li><li><strong>woo_cat_color_67</strong> - </li><li><strong>woo_cat_color_68</strong> - </li><li><strong>woo_cat_color_69</strong> - </li><li><strong>woo_cat_color_7</strong> - </li><li><strong>woo_cat_color_70</strong> - </li><li><strong>woo_cat_color_71</strong> - </li><li><strong>woo_cat_color_72</strong> - </li><li><strong>woo_cat_color_73</strong> - </li><li><strong>woo_cat_color_74</strong> - </li><li><strong>woo_cat_color_75</strong> - </li><li><strong>woo_cat_color_76</strong> - </li><li><strong>woo_cat_color_77</strong> - </li><li><strong>woo_cat_color_78</strong> - </li><li><strong>woo_cat_color_79</strong> - 2F83DE</li><li><strong>woo_cat_color_8</strong> - </li><li><strong>woo_cat_color_80</strong> - </li><li><strong>woo_cat_color_81</strong> - </li><li><strong>woo_cat_color_82</strong> - </li><li><strong>woo_cat_color_83</strong> - </li><li><strong>woo_cat_color_84</strong> - </li><li><strong>woo_cat_color_85</strong> - </li><li><strong>woo_cat_color_86</strong> - </li><li><strong>woo_cat_color_87</strong> - </li><li><strong>woo_cat_color_88</strong> - </li><li><strong>woo_cat_color_89</strong> - </li><li><strong>woo_cat_color_9</strong> - </li><li><strong>woo_cat_color_90</strong> - </li><li><strong>woo_cat_color_91</strong> - </li><li><strong>woo_cat_color_92</strong> - </li><li><strong>woo_cat_color_93</strong> - </li><li><strong>woo_cat_color_94</strong> - </li><li><strong>woo_cat_color_95</strong> - </li><li><strong>woo_cat_color_96</strong> - </li><li><strong>woo_cat_color_97</strong> - </li><li><strong>woo_cat_color_98</strong> - </li><li><strong>woo_cat_color_99</strong> - </li><li><strong>woo_cat_nav_1</strong> - true</li><li><strong>woo_cat_nav_10</strong> - true</li><li><strong>woo_cat_nav_100</strong> - false</li><li><strong>woo_cat_nav_101</strong> - true</li><li><strong>woo_cat_nav_102</strong> - true</li><li><strong>woo_cat_nav_103</strong> - true</li><li><strong>woo_cat_nav_104</strong> - true</li><li><strong>woo_cat_nav_105</strong> - true</li><li><strong>woo_cat_nav_106</strong> - false</li><li><strong>woo_cat_nav_107</strong> - false</li><li><strong>woo_cat_nav_109</strong> - false</li><li><strong>woo_cat_nav_11</strong> - true</li><li><strong>woo_cat_nav_12</strong> - true</li><li><strong>woo_cat_nav_126</strong> - false</li><li><strong>woo_cat_nav_127</strong> - false</li><li><strong>woo_cat_nav_13</strong> - true</li><li><strong>woo_cat_nav_131</strong> - false</li><li><strong>woo_cat_nav_135</strong> - false</li><li><strong>woo_cat_nav_136</strong> - false</li><li><strong>woo_cat_nav_137</strong> - false</li><li><strong>woo_cat_nav_138</strong> - false</li><li><strong>woo_cat_nav_14</strong> - true</li><li><strong>woo_cat_nav_141</strong> - false</li><li><strong>woo_cat_nav_142</strong> - false</li><li><strong>woo_cat_nav_144</strong> - false</li><li><strong>woo_cat_nav_15</strong> - true</li><li><strong>woo_cat_nav_16</strong> - false</li><li><strong>woo_cat_nav_160</strong> - false</li><li><strong>woo_cat_nav_162</strong> - false</li><li><strong>woo_cat_nav_165</strong> - false</li><li><strong>woo_cat_nav_169</strong> - false</li><li><strong>woo_cat_nav_17</strong> - true</li><li><strong>woo_cat_nav_171</strong> - false</li><li><strong>woo_cat_nav_172</strong> - false</li><li><strong>woo_cat_nav_173</strong> - false</li><li><strong>woo_cat_nav_174</strong> - false</li><li><strong>woo_cat_nav_175</strong> - false</li><li><strong>woo_cat_nav_176</strong> - false</li><li><strong>woo_cat_nav_177</strong> - false</li><li><strong>woo_cat_nav_178</strong> - false</li><li><strong>woo_cat_nav_18</strong> - true</li><li><strong>woo_cat_nav_19</strong> - true</li><li><strong>woo_cat_nav_20</strong> - false</li><li><strong>woo_cat_nav_21</strong> - true</li><li><strong>woo_cat_nav_22</strong> - true</li><li><strong>woo_cat_nav_23</strong> - true</li><li><strong>woo_cat_nav_24</strong> - false</li><li><strong>woo_cat_nav_25</strong> - true</li><li><strong>woo_cat_nav_26</strong> - true</li><li><strong>woo_cat_nav_27</strong> - true</li><li><strong>woo_cat_nav_28</strong> - false</li><li><strong>woo_cat_nav_29</strong> - true</li><li><strong>woo_cat_nav_3</strong> - true</li><li><strong>woo_cat_nav_30</strong> - true</li><li><strong>woo_cat_nav_31</strong> - true</li><li><strong>woo_cat_nav_32</strong> - true</li><li><strong>woo_cat_nav_35</strong> - true</li><li><strong>woo_cat_nav_37</strong> - true</li><li><strong>woo_cat_nav_38</strong> - true</li><li><strong>woo_cat_nav_39</strong> - true</li><li><strong>woo_cat_nav_4</strong> - false</li><li><strong>woo_cat_nav_40</strong> - true</li><li><strong>woo_cat_nav_41</strong> - true</li><li><strong>woo_cat_nav_42</strong> - true</li><li><strong>woo_cat_nav_46</strong> - false</li><li><strong>woo_cat_nav_49</strong> - true</li><li><strong>woo_cat_nav_5</strong> - true</li><li><strong>woo_cat_nav_50</strong> - false</li><li><strong>woo_cat_nav_51</strong> - true</li><li><strong>woo_cat_nav_52</strong> - true</li><li><strong>woo_cat_nav_53</strong> - true</li><li><strong>woo_cat_nav_54</strong> - true</li><li><strong>woo_cat_nav_55</strong> - true</li><li><strong>woo_cat_nav_56</strong> - true</li><li><strong>woo_cat_nav_57</strong> - true</li><li><strong>woo_cat_nav_58</strong> - false</li><li><strong>woo_cat_nav_59</strong> - true</li><li><strong>woo_cat_nav_6</strong> - true</li><li><strong>woo_cat_nav_60</strong> - false</li><li><strong>woo_cat_nav_61</strong> - true</li><li><strong>woo_cat_nav_62</strong> - true</li><li><strong>woo_cat_nav_63</strong> - false</li><li><strong>woo_cat_nav_64</strong> - true</li><li><strong>woo_cat_nav_65</strong> - true</li><li><strong>woo_cat_nav_66</strong> - false</li><li><strong>woo_cat_nav_67</strong> - true</li><li><strong>woo_cat_nav_68</strong> - false</li><li><strong>woo_cat_nav_69</strong> - true</li><li><strong>woo_cat_nav_7</strong> - true</li><li><strong>woo_cat_nav_70</strong> - true</li><li><strong>woo_cat_nav_71</strong> - true</li><li><strong>woo_cat_nav_72</strong> - true</li><li><strong>woo_cat_nav_73</strong> - true</li><li><strong>woo_cat_nav_74</strong> - true</li><li><strong>woo_cat_nav_75</strong> - true</li><li><strong>woo_cat_nav_76</strong> - true</li><li><strong>woo_cat_nav_77</strong> - true</li><li><strong>woo_cat_nav_78</strong> - true</li><li><strong>woo_cat_nav_79</strong> - true</li><li><strong>woo_cat_nav_8</strong> - true</li><li><strong>woo_cat_nav_80</strong> - true</li><li><strong>woo_cat_nav_81</strong> - true</li><li><strong>woo_cat_nav_82</strong> - true</li><li><strong>woo_cat_nav_83</strong> - true</li><li><strong>woo_cat_nav_84</strong> - false</li><li><strong>woo_cat_nav_85</strong> - true</li><li><strong>woo_cat_nav_86</strong> - true</li><li><strong>woo_cat_nav_87</strong> - true</li><li><strong>woo_cat_nav_88</strong> - true</li><li><strong>woo_cat_nav_89</strong> - true</li><li><strong>woo_cat_nav_9</strong> - true</li><li><strong>woo_cat_nav_90</strong> - true</li><li><strong>woo_cat_nav_91</strong> - true</li><li><strong>woo_cat_nav_92</strong> - true</li><li><strong>woo_cat_nav_93</strong> - true</li><li><strong>woo_cat_nav_94</strong> - true</li><li><strong>woo_cat_nav_95</strong> - true</li><li><strong>woo_cat_nav_96</strong> - true</li><li><strong>woo_cat_nav_97</strong> - true</li><li><strong>woo_cat_nav_98</strong> - true</li><li><strong>woo_cat_nav_99</strong> - true</li><li><strong>woo_custom_css</strong> - </li><li><strong>woo_custom_favicon</strong> - </li><li><strong>woo_feedburner_url</strong> - </li><li><strong>woo_google_analytics</strong> - <script type=\"text/javascript\">
var gaJsHost = ((\"https:\" == document.location.protocol) ? \"https://ssl.\" : \"http://www.\");
document.write(unescape(\"%3Cscript src=\'\" + gaJsHost + \"google-analytics.com/ga.js\' type=\'text/javascript\'%3E%3C/script%3E\"));
</script>
<script type=\"text/javascript\">
try {
var pageTracker = _gat._getTracker(\"UA-13204227-1\");
pageTracker._trackPageview();
} catch(err) {}</script></li><li><strong>woo_logo</strong> - </li><li><strong>woo_manual</strong> - http://www.woothemes.com/support/theme-documentation/wootheme/</li><li><strong>woo_post_size</strong> - false</li><li><strong>woo_resize</strong> - false</li><li><strong>woo_shortname</strong> - woo</li><li><strong>woo_sidebar_ad_href_1</strong> - http://www.woothemes.com</li><li><strong>woo_sidebar_ad_href_2</strong> - http://www.woothemes.com</li><li><strong>woo_sidebar_ad_href_3</strong> - http://www.woothemes.com</li><li><strong>woo_sidebar_ad_href_4</strong> - http://www.woothemes.com</li><li><strong>woo_sidebar_ad_img_1</strong> - http://www.woothemes.com/ads/woothemes-125x125-1.gif</li><li><strong>woo_sidebar_ad_img_2</strong> - http://www.woothemes.com/ads/woothemes-125x125-2.gif</li><li><strong>woo_sidebar_ad_img_3</strong> - http://www.woothemes.com/ads/woothemes-125x125-3.gif</li><li><strong>woo_sidebar_ad_img_4</strong> - http://www.woothemes.com/ads/woothemes-125x125-4.gif</li><li><strong>woo_single_thumb</strong> - true</li><li><strong>woo_themename</strong> - myweblog</li><li><strong>woo_uploads</strong> - a:2:{i:0;s:84:"http://vaccineresistancemovement.org/wp-content/woo_uploads/4-3-banner-oxysilver.jpg";i:1;s:82:"http://vaccineresistancemovement.org/wp-content/woo_uploads/3-banner-oxysilver.jpg";}</li></ul>